World’s First Global Research Institute for Psychedelic Therapies Opens Its Doors
A global team of researchers have launched a first-of-its-kind research institute that will develop psychedelic medicines to treat mental health disorders and other medical conditions. The network is headquartered in Melbourne, Australia, and is supported with a planned investment of at least A$40 million dollars over five years. The newly launched Psychae Institute is the world’s first collaborative …
World’s First Global Research Institute for Psychedelic Therapies Opens Its Doors Read More »